Predictors of Nonadherence to Highly Active Antiretroviral Therapy among HIV-Infected South Indians in Clinical Care: Implications for Developing Adherence Interventions in Resource-Limited Settings

AIDS Patient Care and STDs

Volumn 24, Issue 12, 2010, Pages 795-803

  Venkatesh, Kartik K ^a   Srikrishnan, A K ^b   Mayer, Kenneth H ^a,c,d   Kumarasamy, N ^b   Raminani, Sudha ^d   Thamburaj, E ^a,b   Prasad, Lakshmi ^b   Triche, Elizabeth W ^a   Solomon, Suniti ^b   Safren, Steven A ^d,e  

^a BROWN UNIVERSITY   (United States)

^b YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^c MIRIAM HOSPITAL   (United States)

^d Fenway Community Health   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DISTRESS SYNDROME; FEMALE; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT CARE; RISK FACTOR; TREATMENT DURATION;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; PREDICTIVE VALUE OF TESTS; PSYCHOLOGY; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS;

EID: 78650078710     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0153     Document Type: Article

References (50)

1. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 2003;362:22-29.
2. Palella F, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
3. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 2006;367:817-824.
4. Morineau G, Vun MC, Barennes H, et al. Survival and quality of life among HIV-positive people on antiretroviral therapy in Cambodia. AIDS Patient Care STDs 2009;23: 669-677.
5. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach\2006 revision. www.who.int/hiv/pub/prev-care/en/arvrevision 2003en.pdf. (Last accessed August 2, 2007).
6. World Health Organization. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. www.who.int/hiv/mediacentre/ 2008progressreport/en/index.html (Last accessed February 3, 2009).
7. UNAIDS. UNAIDS/WHO AIDS epidemic update. www.unaids.org/epidemic-update/ (Last accessed May 9, 2008).
8. NACO. Facts and Figures. www.nacoonline.org/facts.htm (Last accessed July 20, 2007).
9. Ammassari A, Trotta MP, Murri B, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S123-S127.
10. Kalichman S. Co-occurence of treatment nonadherence and contiued HIV transmission risk behaviors: Implications for positive prevention interventions. Psychosom Med 2008;70: 593-597.
11. Kozal M, Amico KR, Chiarella J, et al. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS 2004;18:2185-2189.
12. Wilson T, Barron Y, Cohen M, et al. Adherence to anti-retroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. AIDS 2002;34:529-534.
13. Flaks R, Burnman W, Gourley P, Rietmeijer C, Cohn ED HIV transmission risk behavior and its relation to anti-retroviral treatment adherence. Sex Transm Dis 2003; 30:399-404.
14. Kalichman S, Rompa D. HIV treatment adherence and unprotected sex practices among persons receiving anti-retroviral therapy. Sex Transm Dis 2003;79:59-61.
15. Mills EJ, Nachega JB, Buchan I, et al. Adherence to anti-retroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296:679-690.
16. Bisson G, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R. Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr 2008;49:107-110.
17. Byakia-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV anti-retroviral therapy in HIV\+ Ugandan patients purchasing therapy. Int J STD AIDS 2005;16:38-41.
18. Diabate S, Alary M, Koffi CK. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire. AIDS 2007;21:1799-1803.
19. Nachega J, Stein D, Lehman DA, et al. Adherence to anti-retroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004;20:1053-1056.
20. Orrell C, Bangberg DR, Badri M, Wood R. Adherence is not a barrer to successful antiretroviral therapy in South Africa. AIDS 2003;17:1369-1375.
21. Oyugi J, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated meaures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndrome 2004;36: 1100-1102.
22. San Lio M, Carbini R, Germano P, et al. Evaluating adherence to highly active antiretroviral therpay with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique. Clin Infect Dis 2008;46:1609-1616.
23. Weidle P, Wamai N, Solberg P, et al. Adherence to anti-retroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006;368:1587-1594.
24. Shah B, Walshe L, Saple DG, et al. Adherence to anti-retroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis 2007;44:1235-1244.
25. Kumarasamy N, Safran SA, Raminani SR, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care STDs 2005;19:526-537.
26. Safren S, Kumarasamy N, James R, et al. ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care 2005;17:853-862.
27. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. www.who.int/hiv/pub/guidelines/adult/en/index.html (Last accessed August 20, 2007)
28. AIDS Clinical Trials Group (ACTG) National Institutes of Allergy and Infectious Diseases (NIAID). ACTG ADH/QOL Int 09-23-04: NIAID; 2004.
29. Dugan W, McDonald MV, Passik SD, et al. Use of the Zung Self-Rating Depression Scale in cancer patients: Feasibility as a screening tool. Psychooncology 1998;7:483-493.
30. Babor T, Biddle-Higgins JC, Saunders JB, et al. AUDIT: The Alcohol Use Disorders Identifiction Test: Guidelines For Use In Primary Health Care. Geneva, Switzerland: World Health Organization, 2001.
31. Ewing J. Detecting alcoholism: The CAGE questionnaire. JAMA 1984;252:1905-1907.
32. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for seld-reported HIV medication adherence. AIDS Behav 2008;12:86-94.
33. Cecelia A, Christybai P, Anand S, et al. Usefulness of an observational database to assess antiretroviral treatment trends in India. Natl Med J India 2006;19:14-17.
34. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003;36:79-85.
35. Bangsberg D, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
36. Bangsberg D. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression clinical infectious disease. 2006;43:939-941.
37. Moatti J, Prudhomme J, Traore DC, et al. Access to anti-retroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte d'Ivoire. AIDS 2003;17(Suppl 3):S69-S77.
38. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006;20:85-92.
39. Hendershot C, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: Review and meta-analysis. J Acquir Immune Defic Syndr 2009;52:180-202.
40. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988;128:1185-1197.
41. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-872.
42. Berg C, Michelson SE, Safren SA. Behavioral aspects of HIV care: Adherence, depression, substance use, and HIV-trans-mission behaviors. Infect Dis Clin North Am 2007; 21: 181-200.
43. Chandler G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 2006;43:411-417.
44. Samet J, Cheng DM, Libman H, et al. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 2007;46:194-199.
45. Strauss S, Tiburcio NJ, Munoz-Plaza C, et al. HIV care providers' implementation of routine alcohol reduction support for their patients. AIDS Patient Care STDs 2009;23:211-218.
46. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV\+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: Role of depression in declining adherence over time. AIDS Behav 2009;13(Suppl 1):82-91.
47. Mellins C, Havens JF, McDonnell C, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care 2009;21:168-177.
48. Safren S, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol 2009;28:1-10.
49. Walshe L, Saple DG, Mehta SH, Shah B, Bollinger RC, Gupta A. Physician estimate of antiretroviral adherence in India: Poor correlation with patient self-report and viral load. AIDS Patient Care STDs 2010;24:189-195.
50. Safren S, Kumarasamy N, Hosseinipour M, et al. Perceptions about the acceptability of asessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav 2006;10:443-450.